KalVista Pharmaceuticals (KALV) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts KALV Hot Sheet
Join SI Premium – FREE
KalVista Pharmaceuticals (NASDAQ: KALV) reported Q1 EPS of ($0.87), $0.03 better than the analyst estimate of ($0.90).
For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Gyre Therapeutics (GYRE) files for 30.22M share offering by selling stockholders
- Hyperscale Data reports Bitcoin treasury of 726.9 BTC worth $45.9M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
